Sub menu

 
 

Emerge Health Pty Ltd

Regulatory activities for this sponsor.

Type

Date

21 result(s) found, displaying 1 to 10

  • AusPAR: Cannabidiol

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cannabidiol

  • Epidyolex

    Prescription medicine decision summary
    TGA decision: Epidyolex (cannabidiol) is approved as adjunctive therapy for seizures associated with Dravet and Lennox-Gastaut syndrome

  • AusPAR: Dinutuximab beta

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Dinutuximab beta

  • TRIMBOW (Emerge Health Pty Ltd)

    Prescription medicine registration
    Active ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate; glycopyrronium bromide (glycopyrrolate).

  • Qarziba

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • FOSTAIR (Emerge Health Pty Ltd)

    Prescription medicine registration
    Active ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate.

Help us improve the Therapeutic Goods Administration site